生物股份(600201.SH):子公司取得新獸藥註冊證書
格隆匯7月15日丨生物股份(600201.SH)公吿,根據國家《獸藥管理條例》和《獸藥註冊辦法》規定,經農業農村部審查,批准公司控股子公司遼寧益康生物股份有限公司(“遼寧益康”)與中國農業科學院哈爾濱獸醫研究所、哈爾濱維科生物技術有限公司、哈爾濱國生生物科技股份有限公司、福建聖維生物科技有限公司聯合開發的雞馬立克氏病活疫苗(rMDV-MS-△meq株)為新獸藥,並核發了《新獸藥註冊證書》。
新獸藥名為雞馬立克氏病活疫苗(rMDV-MS-△meq株),用於預防雞馬立克氏病。接種後7日產生免疫力。
在上述新獸藥產品上市銷售前,遼寧益康將按照《獸藥管理條例》、《獸藥產品批准文號管理辦法》的要求,開展產品批准文號申請及報審相關工作。在取得獸藥產品批准文號後,該新獸藥產品方具備上市銷售的條件。
上述新獸藥證書的獲批是公司持續重視研發創新的結果,特別是在非口蹄疫疫苗產品管線上的研發和佈局,將有利於公司更好地為養殖客户提供綜合防疫解決方案,鞏固公司在動物疫苗領域的行業地位,對提升公司研發能力、市場競爭力和可持續發展等方面具有積極的促進作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.